Literature DB >> 28684272

Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years.

Zehong Zhou1, Rong Li1, Jie Qiao2.   

Abstract

Large comparative studies of androgen profiles in women with polycystic ovary syndrome (PCOS) and healthy women are scarce, and the application of the free androgen index (FAI) in diagnosing PCOS has lagged behind in China. Androgen profiles of women aged between 19 and 45 years with PCOS (n = 833) were compared with controls (n = 2732). The women with PCOS had an elevated androgen level (total testosterone, androstenedione and free androgen index) through their reproductive years. In the 'healthy' reference population (consisting of 821 controls without PCOS and without disorders affecting androgen concentrations), FAI, total testosterone and androstenedione were weakly but negatively correlated with age. In women with PCOS, androstenedione was negatively correlated with age (r = -0.106; P = 0.002), whereas increased total testosterone and FAI, and decreased SHBG, were observed in the group aged 40-45 years. After adjusting for body mass index (BMI), age was negatively correlated with FAI and androstenedione, and positively correlated with sex hormone-binding globulin (SHBG) (all P < 0.001). Hyperandrogenaemia seemed to worsen in the oldest women with PCOS, which might be explained by the increasing BMI. About 1.9% of the PCOS control population was diagnosed with PCOS using the FAI upper limit of 6.0, determined by the 95th percentile of the 'healthy' reference group. Body weight management should be emphasized for women with PCOS throughout their lives, and assay of SHBG and FAI is highly recommended in China.
Copyright © 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Androgen; Free androgen index; Polycystic ovary syndrome; Reproductive age

Mesh:

Substances:

Year:  2017        PMID: 28684272     DOI: 10.1016/j.rbmo.2017.05.019

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study.

Authors:  Miaoxian Ou; Pei Xu; Han Lin; Kaichi Ma; Mingxing Liu
Journal:  Int J Endocrinol       Date:  2021-08-12       Impact factor: 3.257

2.  The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome.

Authors:  Vu Ngoc Anh Ho; Toan Duong Pham; Nam Thanh Nguyen; Hieu Le Trung Hoang; Tuong Manh Ho; Lan Ngoc Vuong
Journal:  Clin Exp Reprod Med       Date:  2022-05-27

3.  Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome.

Authors:  Satomi Minato; Naoki Sakane; Kazuhiko Kotani; Shinsuke Nirengi; Ikuyo Hayashi; Akiko Suganuma; Ken Yamaguchi; Kenji Takakura; Narumi Nagai
Journal:  J Clin Med Res       Date:  2018-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.